Quanex Q1 net sales just beat estimates

Reuters
03/06
Quanex Q1 net sales just beat estimates

Overview

  • Building products maker's Q1 net sales rose 2.3%, slightly beating analyst expectations

  • Adjusted EBITDA for Q1 beat analyst expectations

Outlook

  • Quanex estimates fiscal 2026 net sales of $1.84 bln to $1.87 bln

  • Company expects fiscal 2026 Adjusted EBITDA of $240 mln to $245 mln

Result Drivers

  • FOREIGN EXCHANGE AND TARIFFS - Net sales growth driven by foreign exchange translation and tariff pass-through

  • OPERATIONAL COSTS - Higher operational costs at Monterrey plant impacted earnings

  • MACROECONOMIC CHALLENGES - Inflation, high interest rates, and geopolitical tensions weakened demand

Company press release: ID:nGNX4S6jV5

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Sales

Slight Beat*

$409.10 mln

$405.75 mln (4 Analysts)

Q1 Adjusted EPS

Beat

-$0.01

-$0.06 (4 Analysts)

Q1 Adjusted Net Income

Beat

-$300,000

-$2.17 mln (1 Analyst)

Q1 Adjusted EBITDA

Beat

$27.40 mln

$25.64 mln (3 Analysts)

Q1 Gross Margin

24.10%

Q1 Free Cash Flow

-$31.50 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

  • The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the construction supplies & fixtures peer group is "buy."

  • Wall Street's median 12-month price target for Quanex Building Products Corp is $28.50, about 44.9% above its March 4 closing price of $19.67

  • The stock recently traded at 9 times the next 12-month earnings vs. a P/E of 6 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10